尿激酶静脉溶栓治疗早期急性心肌梗死疗效分析

Curative Effect of the Urokinase on Early Acute Myocardial Infarction

目的探讨尿激酶静脉溶栓治疗急性心肌梗死的疗效。方法在心电图监测下,对34例急性心肌梗死患者行尿激酶静脉溶栓治疗。结果 34例患者中冠脉再通22例,再通率达64．7％;未再通12例,其中死亡2例,病死率为16．7％。不同时段溶栓时其并发症的发生率间差别有显著性意义(P<0．005)。结论早期溶栓治疗可减少并发症,降低病死率。

Objective To observe the efficacy of intravenous thrombolytic therapy of urokinase on early acute myocardial infarction （AMI）. Methods Thirty -four patients with AMI were treated by intravenous thrombolytic therapy of urokinase under electrocardiogram monitoring. Results The coronary recanalization were observed in 22 cases, with a recanalization rate of 64. 7% and no recanalization was found in 12 cases. Two patients died, with a mortality rate of 16.7%. The rates of complications during the different stages of thrombolytic therapy were significantly different （ P 〈 0. 005 ）. Conclusion Early application of thrombolytic therapy to AMI can decrease the complication and mortality rate.